New Delhi: Healthcare solutions provider StatsMetrika launched CDISC (Clinical Data Interchange Standards Consortium) Standards, for the first time in India.
Many international drugs and medicine regulatory organizations like the United States Food and Drug Administration (USFDA), the European Medicines Agency (EMA) and Japanese Pharmaceuticals and Medical Devices Agency (PMDA) have, recommended using CDISC.
StatsMetrika is credited for introducing the CDISC standards for the first time in India and helping the firms to comply with the international regulatory standards.
According to StatsMetrika Founder and CEO Gaurav Chauhan the main objective of introducing the CDISC standards is to help the clinical trial and other pharma firms to successfully convert the unstructured data into a standard format with the proprietary process and accelerators.
This process will enable a faster, efficient and reliable conversion of existing clinical trial data to standard domain. The structure would be a part of the regulatory authorities for the review and approval. StatsMetrika, a service and product-oriented company, helps the industries to improve business with unique enterprise solutions.
It aims to provide professional consultancy services in the form of custom software based on user’s needs and problems.